5 April 2014
4QFY14 Results Update | Sector:
Capital Goods
BHEL
BSE SENSEX
22,360
Bloomberg
Equity Shares (m)
M.Cap. (INR b) / (USD b)
52-Week Range (INR)
1, 6, 12 Rel. Per (%)
S&P CNX
6,694
BHEL IN
2,447.6
450.2/7.5
208/100
5/16/-18
Financials & Valuation (INR Million)
Y/E MAR
Net Sales
EBITDA
Adj PAT
Adj.EPS(INR)
Gr. (%)
BV/Sh.(INR)
RoE (%)
RoCE (%)
P/E (x)
P/BV (X)
2014 2015E 2016E
387,725 317,823 350,020
47,216 33,706 47,570
33,789 23,557 36,659
14.4
-46
133
10.7
12.0
12.8
1.4
9.6
-33
140
7.1
6.9
19.1
1.3
15.0
56
149
10.4
10.1
12.3
1.2
CMP: INR184
TP: INR240
Buy
BHEL provisional numbers in-line with estimates:
margins possibly at
normative levels BHEL reported provisional FY14 earnings, with Revenues at
INR404b (down 19.5% YoY), PBT at INR46.8b (down 50% YoY) and PAT at
INR32.3b (down 51% YoY). The numbers are largely in-line with our estimates,
with Revenues at INR404b and PAT at INR33.8b (variance of 4.7%).
Order intake at INR280b in FY14 (vs INR317b in FY13), entails 4QFY14
intake at INR163b:
During 4QFY14, BHEL’s order intake stands at INR168b vs
INR112b in 9mFY14. Key orders received in 4Q includes: i) 1980MW NTPC North
Karanpura (EPC, INR80b), ii) 1600MW NTPC Darlipalli (Boilers, INR30b), iii) hydro
power projects in Punjab / J&K (INR13b), etc. In addition, we understand that
BHEL has emerged as L1 in i) 1320MW Ennore SEZ (EPC, INR78b) ii) 6X196MW
Pranhita Lift Irrigation (~INR25-30b) etc.
Maintain Buy, BHEL is strongly exposed to cyclical factors:
BHEL is strongly
exposed to cyclical factors: i) Contribution margins at ~40-41% vs expected
EBIDTA margin of 12.4% in FY14, leading to a meaningful operating leverage, ii)
Core NWC stable at ~200 days; cyclical factors of retention money (at ~200 days
in FY14E vs 55-60 days in FY07-09) and customer advances (deteriorated from
63% of revenues in FY09 to 34% in FY13) that impacted reported NWC are
expected to normalize, as we expect BTB to increase from 2.2x currently to 3x in
FY15/16E. We maintain
Buy
with a revised Price target of INR240/sh (16x FY16E),
30% upside.
Satyam Agarwal
(AgarwalS@MotilalOswal.com); +91 22 3982 5410
Nirav Vasa
(Nirav.Vasa@MotilalOswal.com); +91 22 3982 5422
Investors are advised to refer through disclosures made at the end of the Research Report.